These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 32306986)

  • 1. Imbalanced cortisol concentrations in glycogen storage disease type I: evidence for a possible link between endocrine regulation and metabolic derangement.
    Rossi A; Simeoli C; Salerno M; Ferrigno R; Della Casa R; Colao A; Strisciuglio P; Parenti G; Pivonello R; Melis D
    Orphanet J Rare Dis; 2020 Apr; 15(1):99. PubMed ID: 32306986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycogen storage disease type Ia (GSDIa) but not Glycogen storage disease type Ib (GSDIb) is associated to an increased risk of metabolic syndrome: possible role of microsomal glucose 6-phosphate accumulation.
    Melis D; Rossi A; Pivonello R; Salerno M; Balivo F; Spadarella S; Muscogiuri G; Casa RD; Formisano P; Andria G; Colao A; Parenti G
    Orphanet J Rare Dis; 2015 Jul; 10():91. PubMed ID: 26219379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-resistance in glycogen storage disease type Ia: linking carbohydrates and mitochondria?
    Rossi A; Ruoppolo M; Formisano P; Villani G; Albano L; Gallo G; Crisci D; Moccia A; Parenti G; Strisciuglio P; Melis D
    J Inherit Metab Dis; 2018 Nov; 41(6):985-995. PubMed ID: 29435782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disturbed sphingolipid metabolism with elevated 1-deoxysphingolipids in glycogen storage disease type I - A link to metabolic control.
    Hornemann T; Alecu I; Hagenbuch N; Zhakupova A; Cremonesi A; Gautschi M; Jung HH; Meienberg F; Bilz S; Christ E; Baumgartner MR; Hochuli M
    Mol Genet Metab; 2018 Sep; 125(1-2):73-78. PubMed ID: 30037504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucose-6-phosphatase deficiency.
    Froissart R; Piraud M; Boudjemline AM; Vianey-Saban C; Petit F; Hubert-Buron A; Eberschweiler PT; Gajdos V; Labrune P
    Orphanet J Rare Dis; 2011 May; 6():27. PubMed ID: 21599942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensorineural hearing loss in GSD type I patients. A newly recognized symptomatic association of potential clinical significance and unclear pathomechanism.
    Iwanicka-Pronicka K; Trubicka J; Szymanska E; Ciara E; Rokicki D; Pollak A; Pronicki M
    Int J Pediatr Otorhinolaryngol; 2021 Dec; 151():110970. PubMed ID: 34775139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mutation in the SLC37A4 gene of glycogen storage disease type Ib in 15 families of the mainland of China].
    Qiu ZQ; Lu CX; Wang W; Qiu JJ; Wei M
    Zhonghua Er Ke Za Zhi; 2011 Mar; 49(3):203-8. PubMed ID: 21575371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adrenal gland hypofunction in active polymyalgia rheumatica. effect of glucocorticoid treatment on adrenal hormones and interleukin 6.
    Cutolo M; Straub RH; Foppiani L; Prete C; Pulsatelli L; Sulli A; Boiardi L; Macchioni P; Giusti M; Pizzorni C; Seriolo B; Salvarani C
    J Rheumatol; 2002 Apr; 29(4):748-56. PubMed ID: 11950017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 11beta-Hydroxysteroid dehydrogenase types 1 and 2 are up- and downregulated in cortisol-secreting adrenal adenomas.
    Mazzocchi G; Malendowicz LK; Aragona F; Tortorella C; Gottardo L; Nussdorfer GG
    J Investig Med; 2002 Jul; 50(4):288-92. PubMed ID: 12109593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver transplantation in glycogen storage disease type I.
    Boers SJ; Visser G; Smit PG; Fuchs SA
    Orphanet J Rare Dis; 2014 Apr; 9():47. PubMed ID: 24716823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Gene mutations and clinical manifestations in children with glycogen storage disease type Ib].
    Liang CL; Liu L; Sheng HY; Jiang MY; Yin X; Mei HF; Cheng J; Zhang W; Fan LP
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Aug; 15(8):661-5. PubMed ID: 23965881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Correlations between the hypothalamo-pituitary-adrenal axis and the metabolic syndrome].
    Góth M; Hubina E; Korbonits M
    Orv Hetil; 2005 Jan; 146(2):51-5. PubMed ID: 15724952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypothalamo-pituitary-adrenal axis dysfunction in chronic fatigue syndrome, and the effects of low-dose hydrocortisone therapy.
    Cleare AJ; Miell J; Heap E; Sookdeo S; Young L; Malhi GS; O'Keane V
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3545-54. PubMed ID: 11502777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycemic control and complications in glycogen storage disease type I: Results from the Swiss registry.
    Kaiser N; Gautschi M; Bosanska L; Meienberg F; Baumgartner MR; Spinas GA; Hochuli M
    Mol Genet Metab; 2019 Apr; 126(4):355-361. PubMed ID: 30846352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison between low-dose (1 microg), standard-dose (250 microg) ACTH stimulation tests and insulin tolerance test in the evaluation of hypothalamo-pituitary-adrenal axis in primary fibromyalgia syndrome.
    Kirnap M; Colak R; Eser C; Ozsoy O; Tutus A; Kelestimur F
    Clin Endocrinol (Oxf); 2001 Oct; 55(4):455-9. PubMed ID: 11678827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of growth hormone replacement therapy on adrenal androgen secretion in adult onset hypopituitarism.
    Isidori AM; Kaltsas GA; Perry L; Burrin JM; Besser GM; Monson JP
    Clin Endocrinol (Oxf); 2003 May; 58(5):601-11. PubMed ID: 12699442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered cortisol metabolism in polycystic ovary syndrome: insulin enhances 5alpha-reduction but not the elevated adrenal steroid production rates.
    Tsilchorozidou T; Honour JW; Conway GS
    J Clin Endocrinol Metab; 2003 Dec; 88(12):5907-13. PubMed ID: 14671189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary exacerbation of metabolic stress leads to accelerated hepatic carcinogenesis in glycogen storage disease type Ia.
    Gjorgjieva M; Calderaro J; Monteillet L; Silva M; Raffin M; Brevet M; Romestaing C; Roussel D; Zucman-Rossi J; Mithieux G; Rajas F
    J Hepatol; 2018 Nov; 69(5):1074-1087. PubMed ID: 30193922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Untargeted plasma metabolomics identifies broad metabolic perturbations in glycogen storage disease type I.
    Mathis T; Poms M; Köfeler H; Gautschi M; Plecko B; Baumgartner MR; Hochuli M
    J Inherit Metab Dis; 2022 Mar; 45(2):235-247. PubMed ID: 34671989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of microsomal cortisol production by (-)-epigallocatechin-3-gallate through a redox shift in the endoplasmic reticulum--a potential new target for treating obesity-related diseases.
    Szelényi P; Révész K; Konta L; Tüttõ A; Mandl J; Kereszturi É; Csala M
    Biofactors; 2013; 39(5):534-41. PubMed ID: 23554216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.